One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
A Patient With Kidney Failure, Polyclonal Hypergammaglobulinemia, and Lymphadenopathy: A Quiz
KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitis
A Patient-Level Analysis of Home Dialysis and Employer-Provided Health Insurance in Kidney Failure
Incorporating Patient and Provider Preferences in Risk Prediction Models
Continuous Kidney Replacement Therapy–Induced Hypophosphatemia: A Nuisance or a Clinically Meaningful Target?
Measuring Relationships Between Dialysis Facilities and Vascular Access Surgeons
Changes in Employment Status After Initiation of Peritoneal and In-Center Hemodialysis
Development of a Mortality Risk Prediction Tool for People With Kidney Failure: A Nominal Group Technique Study of End-User Priorities
Hemodialysis Facilities, Vascular Access Surgeons, and Central Venous Catheter Use: A Retrospective Cohort Study
Hypophosphatemia During Kidney Replacement Therapy and Ventilator-Free Days: A Post Hoc Analysis of the STARRT-AKI Trial
Response to Rituximab as a Maintenance Therapy in Adult Idiopathic Nephrotic Syndrome: A French Multicenter Cohort Study
Accelerometry-Derived Physical Activity Levels and Mortality in Hemodialysis Patients: A Prospective Cohort Study
Relationship Between Baseline and Longitudinal Self-Reported Physical Function and Cardiorenal Outcomes in CKD: Findings From the CRIC Study
Association of Recurrent Atrial Fibrillation With Subsequent Kidney Function Decline in Adults Receiving Rhythm Control Therapy
An Economic Evaluation of a One-Day Living Kidney Donor Evaluation Process Compared to the Usual Approach
Cumulative Effects of Vicadrostat and Empagliflozin on Albuminuria in CKD
The Roles of A Proliferation-Inducing Ligand (APRIL) and B-Cell Activating Factor (BAFF) in IgA Nephropathy
Navigating Anemia Therapy in CKD With Hypoxia-Inducible Factor Activators: A Review
Kidney and Cardiovascular Protection in Diabetes: Beyond Diabetes Typology
